Clinical Trial Update: Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bortezomib and dexamethasone with or without cyclophosphamide in relapsed or uncontrolled multiple myeloma; results have been posted af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2014-08-15